These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 15218838)

  • 1. Protecting consumers from counterfeit drugs.
    FDA Consum; 2004; 38(3):12-3. PubMed ID: 15218838
    [No Abstract]   [Full Text] [Related]  

  • 2. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 3. Curbing counterfeit drugs.
    FDA Consum; 2006; 40(5):11. PubMed ID: 17326307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

  • 5. Update on counterfeit drugs.
    FDA Consum; 2005; 39(5):6-7. PubMed ID: 16419283
    [No Abstract]   [Full Text] [Related]  

  • 6. Counterfeit drugs.
    Rudolf PM; Bernstein IB
    N Engl J Med; 2004 Apr; 350(14):1384-6. PubMed ID: 15070787
    [No Abstract]   [Full Text] [Related]  

  • 7. [Illegal drug trade discovered in Bavaria. How can we protect ourselves from drug falsification?].
    Schweim HG
    MMW Fortschr Med; 2005 Sep; 147(38):11. PubMed ID: 16218221
    [No Abstract]   [Full Text] [Related]  

  • 8. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of compounding on sterility and stability of drugs.
    Hardee GE
    J Am Vet Med Assoc; 1994 Jul; 205(2):224-5. PubMed ID: 7928582
    [No Abstract]   [Full Text] [Related]  

  • 10. Are there fakes and frauds in your nebulizer?
    Allergy & Asthma Network Mothers of Asthmatics
    School Nurse News; 2005 Mar; 22(2):15-7. PubMed ID: 15875950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.
    Nsimba SE
    East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirtieth report.
    World Health Organ Tech Rep Ser; 1987; 748():1-50. PubMed ID: 3111103
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug counterfeiting and counter measures. Study by the Hungarian National Alliance Against Drug Counterfeiting].
    Psychiatr Hung; 2009; 24(3):205-14. PubMed ID: 20017282
    [No Abstract]   [Full Text] [Related]  

  • 15. Deterring the importation of counterfeit pharmaceutical products.
    Stearn DW
    Food Drug Law J; 2004; 59(4):537-61. PubMed ID: 15875351
    [No Abstract]   [Full Text] [Related]  

  • 16. New recommendations to modernize drug manufacturing.
    FDA Consum; 2007; 41(1):4. PubMed ID: 17354283
    [No Abstract]   [Full Text] [Related]  

  • 17. Sterility of extemporaneously compounded preservative-free injections.
    Levchuk JW
    Am J Hosp Pharm; 1991 Jan; 48(1):71-2. PubMed ID: 2053941
    [No Abstract]   [Full Text] [Related]  

  • 18. Combating counterfeit drugs.
    Lancet; 2008 May; 371(9624):1551. PubMed ID: 18468523
    [No Abstract]   [Full Text] [Related]  

  • 19. Adulteration of drugs and foods: compendial approaches to lowering risk.
    Abernethy DR; Sheehan C; Griffiths JC; Williams RL;
    Clin Pharmacol Ther; 2009 Apr; 85(4):444-7. PubMed ID: 18463621
    [No Abstract]   [Full Text] [Related]  

  • 20. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
    Hyde TD
    Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.